Logo image of ESRT

EMPIRE STATE REALTY TRUST-A (ESRT) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:ESRT - US2921041065 - REIT

6.98 USD
+0.14 (+2.05%)
Last: 12/9/2025, 12:06:11 PM
Fundamental Rating

4

Taking everything into account, ESRT scores 4 out of 10 in our fundamental rating. ESRT was compared to 128 industry peers in the Diversified REITs industry. Both the profitability and the financial health of ESRT get a neutral evaluation. Nothing too spectacular is happening here. ESRT has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

ESRT had positive earnings in the past year.
ESRT had a positive operating cash flow in the past year.
In multiple years ESRT reported negative net income over the last 5 years.
In the past 5 years ESRT always reported a positive cash flow from operatings.
ESRT Yearly Net Income VS EBIT VS OCF VS FCFESRT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

ESRT's Return On Assets of 0.85% is in line compared to the rest of the industry. ESRT outperforms 51.56% of its industry peers.
ESRT has a Return On Equity (3.25%) which is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 2.87%, ESRT is in line with its industry, outperforming 54.69% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for ESRT is in line with the industry average of 3.05%.
The 3 year average ROIC (2.75%) for ESRT is below the current ROIC(2.87%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.85%
ROE 3.25%
ROIC 2.87%
ROA(3y)1.03%
ROA(5y)0.49%
ROE(3y)4.33%
ROE(5y)2.08%
ROIC(3y)2.75%
ROIC(5y)2.24%
ESRT Yearly ROA, ROE, ROICESRT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6

1.3 Margins

ESRT has a Profit Margin (4.55%) which is in line with its industry peers.
ESRT's Profit Margin has declined in the last couple of years.
ESRT's Operating Margin of 18.68% is in line compared to the rest of the industry. ESRT outperforms 44.53% of its industry peers.
ESRT's Operating Margin has been stable in the last couple of years.
ESRT has a worse Gross Margin (54.04%) than 75.00% of its industry peers.
In the last couple of years the Gross Margin of ESRT has remained more or less at the same level.
Industry RankSector Rank
OM 18.68%
PM (TTM) 4.55%
GM 54.04%
OM growth 3Y14.11%
OM growth 5Y-0.46%
PM growth 3YN/A
PM growth 5Y-1.77%
GM growth 3Y-0.96%
GM growth 5Y-0.19%
ESRT Yearly Profit, Operating, Gross MarginsESRT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

4

2. Health

2.1 Basic Checks

ESRT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, ESRT has more shares outstanding
Compared to 5 years ago, ESRT has less shares outstanding
The debt/assets ratio for ESRT is higher compared to a year ago.
ESRT Yearly Shares OutstandingESRT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
ESRT Yearly Total Debt VS Total AssetsESRT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

Based on the Altman-Z score of 0.59, we must say that ESRT is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.59, ESRT is in line with its industry, outperforming 55.47% of the companies in the same industry.
ESRT has a Debt/Equity ratio of 1.92. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.92, ESRT is doing worse than 68.75% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.92
Debt/FCF N/A
Altman-Z 0.59
ROIC/WACC0.48
WACC5.99%
ESRT Yearly LT Debt VS Equity VS FCFESRT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

ESRT has a Current Ratio of 2.59. This indicates that ESRT is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.59, ESRT belongs to the top of the industry, outperforming 89.06% of the companies in the same industry.
ESRT has a Quick Ratio of 2.59. This indicates that ESRT is financially healthy and has no problem in meeting its short term obligations.
ESRT's Quick ratio of 2.59 is amongst the best of the industry. ESRT outperforms 89.06% of its industry peers.
Industry RankSector Rank
Current Ratio 2.59
Quick Ratio 2.59
ESRT Yearly Current Assets VS Current LiabilitesESRT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 37.50% over the past year.
Measured over the past years, ESRT shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.83% on average per year.
The Revenue has been growing slightly by 0.45% in the past year.
Measured over the past years, ESRT shows a small growth in Revenue. The Revenue has been growing by 0.98% on average per year.
EPS 1Y (TTM)37.5%
EPS 3YN/A
EPS 5Y-8.83%
EPS Q2Q%187.5%
Revenue 1Y (TTM)0.45%
Revenue growth 3Y7.16%
Revenue growth 5Y0.98%
Sales Q2Q%-20.64%

3.2 Future

ESRT is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -37.27% yearly.
ESRT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.75% yearly.
EPS Next Y-88.67%
EPS Next 2Y-68.83%
EPS Next 3Y-56.74%
EPS Next 5Y-37.27%
Revenue Next Year0.75%
Revenue Next 2Y1.81%
Revenue Next 3Y1.71%
Revenue Next 5Y1.75%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ESRT Yearly Revenue VS EstimatesESRT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 200M 400M 600M 800M
ESRT Yearly EPS VS EstimatesESRT Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.2 0.4 0.6 0.8

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 7.93, which indicates a rather cheap valuation of ESRT.
Based on the Price/Earnings ratio, ESRT is valued cheaply inside the industry as 95.31% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 26.34. ESRT is valued rather cheaply when compared to this.
ESRT is valuated quite expensively with a Price/Forward Earnings ratio of 114.05.
The rest of the industry has a similar Price/Forward Earnings ratio as ESRT.
ESRT is valuated expensively when we compare the Price/Forward Earnings ratio to 23.56, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 7.93
Fwd PE 114.05
ESRT Price Earnings VS Forward Price EarningsESRT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ESRT indicates a rather cheap valuation: ESRT is cheaper than 89.06% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.22
ESRT Per share dataESRT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

A cheap valuation may be justified as ESRT's earnings are expected to decrease with -56.74% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-68.83%
EPS Next 3Y-56.74%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.04%, ESRT has a reasonable but not impressive dividend return.
With a Dividend Yield of 2.04, ESRT pays less dividend than the industry average, which is at 6.59. 85.16% of the companies listed in the same industry pay a better dividend than ESRT!
ESRT's Dividend Yield is comparable with the S&P500 average which is at 2.31.
Industry RankSector Rank
Dividend Yield 2.04%

5.2 History

The dividend of ESRT decreases each year by -17.38%.
ESRT has been paying a dividend for at least 10 years, so it has a reliable track record.
ESRT has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-17.38%
Div Incr Years0
Div Non Decr Years3
ESRT Yearly Dividends per shareESRT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

ESRT pays out 79.65% of its income as dividend. This is not a sustainable payout ratio.
ESRT's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP79.65%
EPS Next 2Y-68.83%
EPS Next 3Y-56.74%
ESRT Yearly Income VS Free CF VS DividendESRT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M
ESRT Dividend Payout.ESRT Dividend Payout, showing the Payout Ratio.ESRT Dividend Payout.PayoutRetained Earnings

EMPIRE STATE REALTY TRUST-A

NYSE:ESRT (12/9/2025, 12:06:11 PM)

6.98

+0.14 (+2.05%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)10-29 2025-10-29/amc
Earnings (Next)02-17 2026-02-17/amc
Inst Owners100.65%
Inst Owner Change3.69%
Ins Owners0.08%
Ins Owner Change0%
Market Cap1.19B
Revenue(TTM)766.65M
Net Income(TTM)34.89M
Analysts75
Price Target8.73 (25.07%)
Short Float %3.31%
Short Ratio3.3
Dividend
Industry RankSector Rank
Dividend Yield 2.04%
Yearly Dividend0.17
Dividend Growth(5Y)-17.38%
DP79.65%
Div Incr Years0
Div Non Decr Years3
Ex-Date09-15 2025-09-15 (0.035)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.39%
PT rev (3m)-3.39%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-22.22%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.04%
Valuation
Industry RankSector Rank
PE 7.93
Fwd PE 114.05
P/S 1.55
P/FCF N/A
P/OCF 4.48
P/B 1.11
P/tB 4.33
EV/EBITDA 9.22
EPS(TTM)0.88
EY12.61%
EPS(NY)0.06
Fwd EY0.88%
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)1.56
OCFY22.32%
SpS4.5
BVpS6.31
TBVpS1.61
PEG (NY)N/A
PEG (5Y)N/A
Graham Number11.18
Profitability
Industry RankSector Rank
ROA 0.85%
ROE 3.25%
ROCE 3.64%
ROIC 2.87%
ROICexc 2.99%
ROICexgc 3.79%
OM 18.68%
PM (TTM) 4.55%
GM 54.04%
FCFM N/A
ROA(3y)1.03%
ROA(5y)0.49%
ROE(3y)4.33%
ROE(5y)2.08%
ROIC(3y)2.75%
ROIC(5y)2.24%
ROICexc(3y)2.99%
ROICexc(5y)2.46%
ROICexgc(3y)3.81%
ROICexgc(5y)3.15%
ROCE(3y)3.48%
ROCE(5y)2.83%
ROICexgc growth 3Y18.9%
ROICexgc growth 5Y-2.68%
ROICexc growth 3Y19.87%
ROICexc growth 5Y-1.77%
OM growth 3Y14.11%
OM growth 5Y-0.46%
PM growth 3YN/A
PM growth 5Y-1.77%
GM growth 3Y-0.96%
GM growth 5Y-0.19%
F-Score6
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 1.92
Debt/FCF N/A
Debt/EBITDA 6.18
Cap/Depr 140.72%
Cap/Sales 34.79%
Interest Coverage 1.49
Cash Conversion 79.7%
Profit Quality N/A
Current Ratio 2.59
Quick Ratio 2.59
Altman-Z 0.59
F-Score6
WACC5.99%
ROIC/WACC0.48
Cap/Depr(3y)133.09%
Cap/Depr(5y)115.91%
Cap/Sales(3y)34.64%
Cap/Sales(5y)32.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.5%
EPS 3YN/A
EPS 5Y-8.83%
EPS Q2Q%187.5%
EPS Next Y-88.67%
EPS Next 2Y-68.83%
EPS Next 3Y-56.74%
EPS Next 5Y-37.27%
Revenue 1Y (TTM)0.45%
Revenue growth 3Y7.16%
Revenue growth 5Y0.98%
Sales Q2Q%-20.64%
Revenue Next Year0.75%
Revenue Next 2Y1.81%
Revenue Next 3Y1.71%
Revenue Next 5Y1.75%
EBIT growth 1Y-8.53%
EBIT growth 3Y22.28%
EBIT growth 5Y0.51%
EBIT Next Year124.48%
EBIT Next 3Y34.61%
EBIT Next 5Y20.13%
FCF growth 1Y96.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.72%
OCF growth 3Y7.08%
OCF growth 5Y2.32%

EMPIRE STATE REALTY TRUST-A / ESRT FAQ

Can you provide the ChartMill fundamental rating for EMPIRE STATE REALTY TRUST-A?

ChartMill assigns a fundamental rating of 4 / 10 to ESRT.


What is the valuation status of EMPIRE STATE REALTY TRUST-A (ESRT) stock?

ChartMill assigns a valuation rating of 4 / 10 to EMPIRE STATE REALTY TRUST-A (ESRT). This can be considered as Fairly Valued.


How profitable is EMPIRE STATE REALTY TRUST-A (ESRT) stock?

EMPIRE STATE REALTY TRUST-A (ESRT) has a profitability rating of 4 / 10.


How financially healthy is EMPIRE STATE REALTY TRUST-A?

The financial health rating of EMPIRE STATE REALTY TRUST-A (ESRT) is 4 / 10.


What is the expected EPS growth for EMPIRE STATE REALTY TRUST-A (ESRT) stock?

The Earnings per Share (EPS) of EMPIRE STATE REALTY TRUST-A (ESRT) is expected to decline by -88.67% in the next year.